Quick Answer
MDxHealth SA reported Research And Development Expense of $10.55 million for the year ending 2024.
- MDxHealth SA showed an increase of +65.5% in Research And Development Expense from 2023 to 2024.
- This data is from MDxHealth SA's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2019 to 2024), MDxHealth SA's Research And Development Expense has grown by 17.3%.
- Historical annual values: Fiscal year 2024: $10.55 million | Fiscal year 2023: $6.38 million | Fiscal year 2022: $5.50 million | Fiscal year 2021: $5.59 million | Fiscal year 2020: $4.54 million | Fiscal year 2019: $9.00 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: